A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT05478785 · UNKNOWN
Trial details
- NCT number
- NCT05478785
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-12-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.